Covance, the drug development business of Laboratory Corporation of America Holdings (LabCorp), is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real® by providing high-quality nonclinical, clinical and commercialization services to pharmaceutical and biotechnology companies to help reduce the time and costs associated with drug development. Because of our broad experience and specialized expertise, we’re in a unique position to supply insights that go above and beyond testing -- We have helped pharmaceutical and biotech companies develop each of the top 50 prescription drugs in the marketplace today. We also offer laboratory testing services to the chemical, agrochemical and food industries and are a market leader in toxicology services, central laboratory services, discovery services, and a top global provider of Phase III clinical trial management services. Together with our clients, we create solutions that transform potential into reality.
Princeton, US
Covance was founded in 1968 and is headquartered in Princeton, US

Covance Office Locations

Covance has an office in Princeton

Covance Financials and Metrics

Covance Summary

Founding Date

Covance is a subsidiary of Laboratory Corporation of America Holdings

Covance Financials

Covance's revenue was reported to be $2.6 b in FY, 2013
USDFY, 2013


2.6 b

Net Income

179.2 m
USDFY, 2013


617.7 m

Accounts Receivable

331.8 m


201.6 m

Current Assets

1.5 b
USDFY, 2013

Net Income

179.2 m

Depreciation and Amortization

127.9 m

Accounts Receivable

7.7 m


(1.3 m)
Show all financial metrics

Covance Median Salaries

Source: 28 public H-1B filings from Covance

Covance's Web-traffic and Trends

Covance Online and Social Media Presence

Covance News and Updates

Lilly used nursing services as kickbacks to boost insulin prescriptions, lawsuit claims

Amid allegations about price hikes on key insulin products Humulin and Humalog, Eli Lilly is facing a lawsuit claiming it ran a "multi-tiered kickback scheme" to pump up sales of the same drugs.

Global Early Phase Clinical Trial Outsourcings Market 2017 Share, Trend, Segmentation and Forecast to 2022

Early Phase Clinical Trial Outsourcings Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022 Posted via Industry Today. Follow us on Twitter @IndustryToday

PE-backed Global ID appoints new CEO

The Global ID Group, a portfolio company of Paine Schwartz Partners, has named Brad Riemenapp as CEO. His appointment becomes effective October. Previously, Riemenapp worked in Covance's food solutions unit where he served as global vice president and general manager. Global ID is a provider of food…

Covance Company Life and Culture

You may also be interested in